| Dec 25 | Dec 24 | Dec 22 | Dec 21 | May 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -616.12K | $ -879.65K | $ -2.63M | $ -3.66M | $ -734.06K |
| EBITDA | $ -616.12K | $ -837.65K | $ -2.28M | $ -3.50M | $ -733.57K |
| Net Income | $ -687.85K | $ -921.98K | $ -2.38M | $ -3.68M | $ -798.46K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.62K | $ 115.02K | $ 220.65K | $ 226.14K | $ 1.54M |
| Total Assets | $ 19.88K | $ 141.61K | $ 261.28K | $ 269.49K | $ 1.92M |
| Total Debt | $ 1.67M | $ 1.59M | $ 1.23M | $ 735.15K | $ 0.00 |
| Net Debt | $ 1.66M | $ 1.48M | $ 1.01M | $ 509.01K | $ -787.09K |
| Total Liabilities | $ 7.50M | $ 6.93M | $ 5.15M | $ 3.07M | $ 228.21K |
| Stockholders' Equity | $ -7.48M | $ -6.79M | $ -4.88M | $ -2.80M | $ 1.70M |
| Cash Flow | |||||
| Free Cash Flow | $ -111.40K | $ -241.16K | $ -690.13K | $ -679.24K | $ -760.77K |
| Operating Cash Flow | $ -111.40K | $ -241.16K | $ -690.13K | $ -679.24K | $ -760.77K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 343.00K | $ 27.64K | $ -572.75K |
| Financing Cash Flow | $ 0.00 | $ 200.00K | $ 341.63K | $ 525.00K | $ 0.00 |
Mosaic ImmunoEngineering Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.